| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human dynein, light chain, roadblock-type 2 (DYNLRB2) from ORIGENE TECHNOLOGIES | TP319143 | 20 ug | ORIGENE TECHNOLOGIES |
| Human dynein, light chain, Tctex-type 1 (DYNLT1) from ORIGENE TECHNOLOGIES | TP318331 | 20 ug | ORIGENE TECHNOLOGIES |
| Human dynein, light chain, Tctex-type 3 (DYNLT3) from ORIGENE TECHNOLOGIES | TP301525 | 20 ug | ORIGENE TECHNOLOGIES |
| Potassium inwardly-rectifying channel, subfamily J, member 16 (KCNJ16), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412965 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium inwardly-rectifying channel, subfamily J, member 16 (KCNJ16), transcript variant 2 from ORIGENE TECHNOLOGIES | LY430319 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium inwardly-rectifying channel, subfamily J, member 16 (KCNJ16), transcript variant 2 from ORIGENE TECHNOLOGIES | LY406861 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium inwardly-rectifying channel, subfamily J, member 16 (KCNJ16), transcript variant 3 from ORIGENE TECHNOLOGIES | LY430320 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium inwardly-rectifying channel, subfamily J, member 16 (KCNJ16), transcript variant 3 from ORIGENE TECHNOLOGIES | LY406862 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium inwardly-rectifying channel, subfamily J, member 4 (KCNJ4), transcript variant 1 from ORIGENE TECHNOLOGIES | LY403495 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium inwardly-rectifying channel, subfamily J, member 4 (KCNJ4), transcript variant 2 from ORIGENE TECHNOLOGIES | LY417610 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium inwardly-rectifying channel, subfamily J, member 1 (KCNJ1), transcript variant rom-k1 from ORIGENE TECHNOLOGIES | LY400081 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium large conductance calcium-activated channel, subfamily M, alpha member 1 (KCNMA1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY400815 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium large conductance calcium-activated channel, subfamily M, beta member 4 (KCNMB4) from ORIGENE TECHNOLOGIES | LY415209 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium large conductance calcium-activated channel, subfamily M beta member 3 (KCNMB3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY406784 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium large conductance calcium-activated channel, subfamily M beta member 3 (KCNMB3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY406785 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium large conductance calcium-activated channel, subfamily M beta member 3 (KCNMB3), transcript variant 3 from ORIGENE TECHNOLOGIES | LY406786 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium large conductance calcium-activated channel, subfamily M beta member 3 (KCNMB3), transcript variant 4 from ORIGENE TECHNOLOGIES | LY415300 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium large conductance calcium-activated channel, subfamily M beta member 3 (KCNMB3), transcript variant 5 from ORIGENE TECHNOLOGIES | LY431138 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium large conductance calcium-activated channel, subfamily M, beta member 2 (KCNMB2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY405752 | 100 ug | ORIGENE TECHNOLOGIES |
| Potassium large conductance calcium-activated channel, subfamily M, beta member 2 (KCNMB2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY401775 | 100 ug | ORIGENE TECHNOLOGIES |
| Human Thryoxine, Free (fT4) ELISA kit from ORIGENE TECHNOLOGIES | EA100836 | 8x12 divisible strips | ORIGENE TECHNOLOGIES |
| Human Thryoxine (T4) ELISA kit from ORIGENE TECHNOLOGIES | EA100834 | 8x12 divisible strips | ORIGENE TECHNOLOGIES |
| Human Thryoxine (T4) ELISA kit from ORIGENE TECHNOLOGIES | EA100973 | 96-well strip plate | ORIGENE TECHNOLOGIES |
| TBR1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN411174 | 1 kit | ORIGENE TECHNOLOGIES |
| Tbr1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN517280 | 1 kit | ORIGENE TECHNOLOGIES |
| Tuberous sclerosis 1 (TSC1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400132 | 100 ug | ORIGENE TECHNOLOGIES |
| Tuberous sclerosis 2 (TSC2), transcript variant 5 from ORIGENE TECHNOLOGIES | LY426483 | 100 ug | ORIGENE TECHNOLOGIES |
| Cell cycle associated protein 1 (CAPRIN1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY416994 | 100 ug | ORIGENE TECHNOLOGIES |
| Cell cycle exit and neuronal differentiation 1 (CEND1) from ORIGENE TECHNOLOGIES | LY402575 | 100 ug | ORIGENE TECHNOLOGIES |
| Cell cycle progression 1 (CCPG1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417782 | 100 ug | ORIGENE TECHNOLOGIES |
| Cell cycle progression 1 (CCPG1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY412364 | 100 ug | ORIGENE TECHNOLOGIES |
| Cell death-inducing DFFA-like effector a (CIDEA), transcript variant 2 from ORIGENE TECHNOLOGIES | LY405009 | 100 ug | ORIGENE TECHNOLOGIES |
| Cell death-inducing DFFA-like effector b (CIDEB) from ORIGENE TECHNOLOGIES | LY415279 | 100 ug | ORIGENE TECHNOLOGIES |
| Cell death-inducing DFFA-like effector c (CIDEC) from ORIGENE TECHNOLOGIES | LY402906 | 100 ug | ORIGENE TECHNOLOGIES |
| Cell division cycle associated 2 (CDCA2) from ORIGENE TECHNOLOGIES | LY407470 | 100 ug | ORIGENE TECHNOLOGIES |
| Cell division cycle associated 3 (CDCA3) from ORIGENE TECHNOLOGIES | LY410572 | 100 ug | ORIGENE TECHNOLOGIES |
| Cell division cycle associated 5 (CDCA5) from ORIGENE TECHNOLOGIES | LY409053 | 100 ug | ORIGENE TECHNOLOGIES |
| Cell division cycle associated 8 (CDCA8) from ORIGENE TECHNOLOGIES | LY402655 | 100 ug | ORIGENE TECHNOLOGIES |
| Cell division cycle associated 4 (CDCA4), transcript variant 1 from ORIGENE TECHNOLOGIES | LY413415 | 100 ug | ORIGENE TECHNOLOGIES |
| Cell division cycle associated 7 (CDCA7), transcript variant 1 from ORIGENE TECHNOLOGIES | LY429791 | 100 ug | ORIGENE TECHNOLOGIES |
| Cell division cycle associated 4 (CDCA4), transcript variant 2 from ORIGENE TECHNOLOGIES | LY407902 | 100 ug | ORIGENE TECHNOLOGIES |
| Cell division cycle associated 7 (CDCA7), transcript variant 1 from ORIGENE TECHNOLOGIES | LY410426 | 100 ug | ORIGENE TECHNOLOGIES |
| Cell division cycle associated 7 (CDCA7), transcript variant 2 from ORIGENE TECHNOLOGIES | LY403465 | 100 ug | ORIGENE TECHNOLOGIES |
| Cell division cycle associated 7-like (CDCA7L), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412891 | 100 ug | ORIGENE TECHNOLOGIES |
| Human thymopoietin (TMPO), transcript variant 2 from ORIGENE TECHNOLOGIES | TP720158 | 10 ug | ORIGENE TECHNOLOGIES |
| Human thymopoietin (TMPO), transcript variant 2 from ORIGENE TECHNOLOGIES | TP308781 | 20 ug | ORIGENE TECHNOLOGIES |
| Human thymopoietin (TMPO), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP761176 | 50ug | ORIGENE TECHNOLOGIES |
| Gamma-glutamyl carboxylase (GGCX), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400291 | 100 ug | ORIGENE TECHNOLOGIES |
| IL11RA - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN400654 | 1 kit | ORIGENE TECHNOLOGIES |
| IL17RA - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN402390 | 1 kit | ORIGENE TECHNOLOGIES |